Enlivex Therapeutics Ltd
ENLV
$1.3-0.52 (-28.57%)
Aug 18, 2025, 3:38 PM
Financials
52Week High | 2.10 | 52Week Low | 0.81 |
Beta | 0.95 | Current Ratio Annual | 6.84 |
Current Ratio Quarterly | 7.20 | Market Cap | 45.08M |
Price To Book | 2.19 | Quick Ratio Annual | 6.27 |
Quick Ratio Quarterly | 6.57 | Return On Assets TTM | -50.52 |
Return On Equity TTM | -57.67 | Return On Investment TTM | -57.67 |
Revenue Per Share TTM | 0.00 |
13F Aggregates
Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 26 | 1 | 0 | 3 | 1 | 0 | 3.43M | $3.99M |
Mar 31, 2025 | 26 | 3(+200%) | 2(+%) | 6(+100%) | 7(+600%) | 9(+%) | 3.22M(-6%) | $3.09M(-23%) |
Jun 30, 2025 | 22(-15%) | 2(-33%) | 7(+250%) | 1(-83%) | 8(+14%) | 8(-11%) | 2.42M(-25%) | $2.70M(-13%) |